Bioactive Plant Compounds as Alternatives Against Antifungal Resistance in the Candida Strains
Pharmaceutics · 23.05.2025 · 17 (6) · 687
DOI: 10.3390/pharmaceutics17060687 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.05.2025. Verfasst von Thainá Dos Santos Dantas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Therapeutic Innovation, Federal University of Pernambuco, Recife 50670-901, Brazil. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco, Conselho Nacional de Desenvolvimento Científico e Tecnológico, National Institute of Science and Technology of the Health Economic-Industrial Complex.
Abstract (Originalsprache)
The pathogenicity of Candida spp. poses a persistent challenge, particularly in hospital environments where these species proliferate and cause opportunistic infections. Many strains have developed resistance to commonly used antifungal agents, including azoles, polyenes, and echinocandins, complicating treatment, especially in immuno-compromised patients. Understanding the mechanisms underlying antifungal resistance, such as mutations in genes involved in ergosterol biosynthesis, efflux pump activity, and enzymatic pathways, is crucial for developing targeted interventions. Given the challenges associated with discovering new antifungal agents, medicinal plants have emerged as a promising source of bioactive compounds with anti-Candida activity. Secondary metabolites, including terpenoids, alkaloids, flavonoids, and tannins, exhibit various mechanisms of action, such as biofilm inhibition, membrane disruption, and oxidative stress induction. However, challenges such as extract standardization, and the lack of clinical studies continue to limit their therapeutic application. This review underscores the potential of medicinal plants as complementary or alternative strategies to conventional antifungal therapies, emphasizing the need for multidisciplinary research to overcome these hurdles and harness the therapeutic potential of natural products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Program in Therapeutic Innovation, Federal University of Pernambuco, Recife 50670-901, Brazil.
- Postgraduate Program in Pharmaceutical Sciences, Federal University of Pernambuco, Recife 50670-901, Brazil.
ORCID-Profile: Thainá Dos Santos Dantas, Luiz Alberto Lira Soares
Förderung
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institute of Science and Technology of the Health Economic-Industrial Complex
Zitieren
APA
Dantas, T. D. S., Machado, J. C. B., Ferreira, M. R. A., & Soares, L. A. L. (2025). Bioactive Plant Compounds as Alternatives Against Antifungal Resistance in the Candida Strains. Pharmaceutics, 17(6), 687. https://doi.org/10.3390/pharmaceutics17060687
Vancouver
Dantas TDS, Machado JCB, Ferreira MRA, Soares LAL. Bioactive Plant Compounds as Alternatives Against Antifungal Resistance in the Candida Strains. Pharmaceutics. 2025;17(6):687. doi:10.3390/pharmaceutics17060687
BibTeX
@article{Dantas2025,
author = {Dantas, Thainá Dos Santos and Machado, Janaina Carla Barbosa and Ferreira, Magda Rhayanny Assunção and Soares, Luiz Alberto Lira},
title = {Bioactive Plant Compounds as Alternatives Against Antifungal Resistance in the Candida Strains},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {6},
pages = {687},
doi = {10.3390/pharmaceutics17060687}
}
EUVIMED